New Treatment Strategies for Prostate Cancer
Combination Treatment: Cryoablation with Radiation
Research
• Purpose
– Explore the use of adjuvant radiation as a way to cryosensitize and enhance direct killing of human prostate cancer cell lines (PC3) and (DU145)
BACKGROUND
• Most common noncutaneous cancer & 2nd leading cause of cancer death in men in the US • Prevalence increases with age
– 1/3 of men in the 4th decade will have foci of cancer – 3/4 of men in the 8th decade will have foci of cancer
BACKGROUND
• Lifetime risk that an American will be diagnosed with CaP is 17 % • Only 16%of men diagnosed with CaP ultimately die from it. • Natural hx varies from indolent to highly aggressive.
CHALLENGE
• Advise treatment in those in whom treatment is necessary. • Due to its prevalence and wide spectrum of aggressiveness different methods of treatment have been developed. • Preferred methods are controversial.
TREATMENT OPTIONS
• Radical prostatectomy
– Perceived as morbid by some
• Radiation Therapy
– Criticized for its uncertain efficacy
CONCERNS
• Regarding conventional treatment have stimulated a search for alternative treatments that are effective and associated with limited morbidity.
CRYOTHERAPY recognized as a therapeutic option in 1996
• Investigational label was removed • Offers minimally invasive option
– – – – low morbidity minimal blood loss short hospital stay high rate of negative post treatment biopsies
Cryobiology
• Freezing causes cell death via several mechanisms
– – – – direct cell injury vascular injury apoptosis Up regulation of the immune system.
Direct Cell Death
• Mechanical
– Rapid formation of intracellular and extracellular ice crystals exerting shear forces on cell membranes and organells
• Biochemical
– Ph changes – Osmmolarity
Direct Cell Death
• Complete Cell death is unlikely to occur at temperatures warmer than -40 º C
– This is important to note.
• Edge of ice ball is 0˚C
Vascular Injury
• Endothelial Damage
• This leads to Platelet Aggregation and micro thrombi formation causing tissue ischemia and cell death
Apoptosis
• Temperatures of -5º to -15º C causes mitochondrial-mediated apoptosis
– up-regulation of pro-apoptotic proteins (such as Bax). Apoptosis is thought to be the primary method of cell death in the peripheral zone.
Activation of Immune System
• Release of cytokines in serum causing activation of immune system.
Morbidities associated with with current cryotherapy
• Impotence: >80%
– With total ablation
• Incontinence: 2% - 10%
– Higher if salvage cryosurgery
• Obstruction: 3.8% to 23%
– Uretheral Sloughing
• Usually 3 -8 wks post treatment
• Fistula: 0% - 3%
– Most commonly seen with previous radiation
Isotherms
• Isotherms extend radially
– -190 degrees C at the probe – and warm to 0 degrees at the ice ball periphery
• On ultrasound the freeze zone periphery (ice ball) is seen as a hyper echoic edge, providing a definable destructive freeze margin
Isotherms
• These isotherms result in two tissue zones:
– A central necrotic zone – A peripheral zone of cell damage, but not necrosis.
Downloaded from: Campbell-Walsh Urology (on 16 May 2007 03:18 AM) © 2007 Elsevier
Isotherms
• Uncertain tissue ablation near the ice ball periphery.
– It is this area which is felt to be the cause of local recurrence
Recurrence Rate
• Positive biopsy rate after cryotherapy ranges between 7.7% and 23%.
Can We Improve Outcomes
• Persistent cancer after cryoablation is felt to represent cell survival in the peripheral zone of the ice ball
– where temperatures are warmer than 40˚C.
Earlier Research
• Previously, we were able to show a synergistic effect on clonogenic inhibition in a human prostate cancer cell line (PC3)
– However this synergy was not statistically different than the radiation only treatment group.
Hypothesis
• That by decreasing the dose of radiation, combined with decreased manipulation (stress) of the cells we would show a statistically significant difference in clonogenic inhibition.
Design
• Pre plated cells cells were exposed to
• Vs. Single cell suspension in prior experiment
• -5˚C, • -10˚C, • -20˚C
– for 30 minutes and thawed at 37˚C
• Or, a combination of the above temperatures with 2 Gy radiation,
– non lethal dose
Design
In combination experiments single dose radiation was given 24 hours prior to cryotherapy same as prior experiment
d i u m
Medium changed
treatment
Cells plated for colony forming assay plated for
colony forming assay
Counted
24 hours 30 minutes:
11 days
Materials Cell Culture
• Human Prostate cancer cell lines (PC3) and (DU145) was used to test the hypothesis. • Pre plated cells were treated
– Prior experiment used
• 80 % confluence Cells cultures were treated then plated
Materials
• Human Prostate cancer cell lines (PC3) and (DU145) were exposed to:
– only (PC3) cell line used with prior experiment
1. 2Gy radiation
c/t 5 Gy with prior experiment
2. -5 degrees C 3. -10 degrees C 4. -20 degrees C 5. Or a combination of radiation and cryotherapy at above temperatures
Data Analysis
• Colonies containing 50 or more cells were counted. Surviving fraction (S.F.) was calculated using the plating efficiency. • Each experimental group was repeated three times to obtain mean and standard deviation.
RESULTS
PC3 cryotreated cells: 5 Gy vs. 2
1.1 1 0.9 0.8 0.7
SF
0.6 0.5 0.4 0.3 0.2 0.1 0 5Gy groups 2Gy
Control pc3 -5 C -10 C -20 IR -5 C/ IR -10 C / IR -20 C / IR
Dose dependent kill with freezing
PC3 VS DU145
1.2 1 0.8
SF
0.6 0.4 0.2 0
0 IR ol C C IR IR nt r -5 -2 0 C/ / -1 / IR
PC3 DU145
C 0 -1
co
-5
groups
Temperature dependant decrease in SF
-2
0
C
PC3 VS DU145
1.2 1 0.8
SF
0.6 0.4 0.2 0
0 IR ol C C IR IR nt r -5 -2 0 C/ / -1 / IR
PC3 DU145
C 0 -1
co
-5
groups
PC3 CELL MORE CRYOSENSITIVE
-2
0
C
PC3 VS DU145
1.2 1 0.8
SF
0.6 0.4 0.2 0
PC3 DU145
0
IR
ol
C
C
IR
IR / C 0 -2 0 C
nt r
-5
-1 0
-2
/
co
-5
C
groups
DU 145 CELLS MORE RADIO - RESISTANT
-1
/
IR
Cryotherapy Enhancement Ratio
20 2 15 CER 10 5 0 Series1 Series2 1 1 2 16 2 PC3 and DU145 2 Series1 3 3 3 0 0 Series2
1 3.8 2.3
SIGNIFICANT INCREASES IN CER FOR PC3 CELLS
Conclusion
• Adjuvant radiation, 2 Gy, has a statistically significant synergistic effect on PC3 cells when combined with cryoablation • DU145 cell line appears to be cryo resistant at warmer temperatures,this is of unknown significance • Synergy with radiation appears to be present
– Currently repeating experiment with DU 145 cell line
Current and future studies
• Assess cell death and understand the molecular mechanism of this synergistic effect. • Progress to animal studies
Future treatment regimens
Cryotherapy alone
Cryotherapy + 2 Gy x5
2 Gy x5
2 Gy x5 cryotherapy
sammyc2007 4/15/2008 |
21 |
0 |
0 |
educational
AmnaKhan 4/21/2008 |
202 |
6 |
0 |
educational
sammyc2007 4/17/2008 |
15 |
0 |
0 |
educational
sammyc2007 4/25/2008 |
22 |
1 |
0 |
educational
sammyc2007 4/17/2008 |
28 |
0 |
0 |
educational
sammyc2007 4/17/2008 |
49 |
1 |
0 |
educational
sammyc2007 4/17/2008 |
51 |
1 |
0 |
educational
sammyc2007 4/24/2008 |
71 |
3 |
0 |
educational
sammyc2007 4/28/2008 |
52 |
1 |
0 |
educational
AmnaKhan 4/19/2008 |
121 |
0 |
0 |
educational
AmnaKhan 4/21/2008 |
13 |
0 |
0 |
educational
sammyc2007 4/15/2008 |
43 |
1 |
0 |
educational
sammyc2007 4/22/2008 |
26 |
0 |
0 |
educational
sammyc2007 4/24/2008 |
70 |
4 |
0 |
educational
sammyc2007 4/15/2008 |
18 |
0 |
0 |
educational
sammyc2007 6/13/2008 |
112 |
4 |
0 |
legal
sammyc2007 6/13/2008 |
92 |
0 |
0 |
legal
sammyc2007 6/13/2008 |
144 |
4 |
0 |
legal
sammyc2007 6/13/2008 |
133 |
2 |
0 |
legal
sammyc2007 6/13/2008 |
245 |
1 |
0 |
legal
sammyc2007 6/13/2008 |
183 |
0 |
0 |
legal
sammyc2007 6/13/2008 |
104 |
0 |
0 |
legal
sammyc2007 6/13/2008 |
78 |
0 |
0 |
legal
sammyc2007 6/13/2008 |
200 |
0 |
0 |
legal
sammyc2007 6/13/2008 |
129 |
0 |
0 |
legal